Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,032 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful endovascular embolization of the common hepatic artery for pseudoaneurysm associated with pancreatic fistula after liver transplantation: a case report.
Sasaki K, Asaoka T, Kobayashi S, Iwagami Y, Yamada D, Tomimaru Y, Noda T, Wada H, Gotoh K, Takahashi H, Maeda N, Kimura Y, Ono Y, Doki Y, Eguchi H. Sasaki K, et al. Among authors: wada h. Surg Case Rep. 2023 Aug 10;9(1):143. doi: 10.1186/s40792-023-01723-7. Surg Case Rep. 2023. PMID: 37561260 Free PMC article.
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer.
Hasegawa S, Takahashi H, Akita H, Mukai Y, Mikamori M, Asukai K, Yamada D, Wada H, Fujii Y, Sugase T, Yamamoto M, Takeoka T, Shinno N, Hara H, Kanemura T, Haraguchi N, Nishimura J, Matsuda C, Yasui M, Omori T, Miyata H, Ohue M, Ishikawa O, Sakon M. Hasegawa S, et al. Among authors: wada h. BMC Cancer. 2023 Jan 18;23(1):63. doi: 10.1186/s12885-023-10512-2. BMC Cancer. 2023. PMID: 36653747 Free PMC article.
Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer: Long-term Conditional Recurrence-free Survival Analysis in the Setting of a Neoadjuvant Treatment Strategy.
Takahashi H, Akita H, Wada H, Miyata H, Eguchi H, Ohigashi H, Sakon M, Ishikawa O. Takahashi H, et al. Among authors: wada h. Ann Surg. 2023 Dec 1;278(6):e1216-e1223. doi: 10.1097/SLA.0000000000005879. Epub 2023 Apr 14. Ann Surg. 2023. PMID: 37057622
SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor-stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapy.
Takayama H, Kobayashi S, Gotoh K, Sasaki K, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Asaoka T, Noda T, Wada H, Takahashi H, Tanemura M, Doki Y, Eguchi H. Takayama H, et al. Among authors: wada h. J Cancer Res Clin Oncol. 2023 Sep;149(12):10935-10950. doi: 10.1007/s00432-023-04835-7. Epub 2023 Jun 17. J Cancer Res Clin Oncol. 2023. PMID: 37330435
Exploratory prospective, randomized phase II study of neoadjuvant transcatheter arterial chemoembolization plus surgery versus surgery alone for large hepatocellular carcinoma (CSGO-HBP-005): Clinical Study Group of Osaka University, Hepato-Biliary-Pancreatic Group.
Kobayashi S, Tomokuni A, Takeda Y, Wada H, Katsura Y, Hashimoto K, Tomimaru Y, Asaoka T, Yamada T, Tsujie M, Noda T, Morita S, Nagano H, Mori M, Doki Y, Eguchi H; Clinical Study Group of Osaka University, Hepato‐Biliary‐Pancreatic Group. Kobayashi S, et al. Among authors: wada h. Hepatol Res. 2024 Jul;54(7):667-677. doi: 10.1111/hepr.14013. Epub 2024 Jan 27. Hepatol Res. 2024. PMID: 38279693
ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Significance in Patients with a Modest Radiological Response to Neoadjuvant Treatment for Pancreatic Cancer.
Miyahara S, Takahashi H, Akita H, Sasaki K, Mukai Y, Iwagami Y, Hasegawa S, Yamada D, Tomimaru Y, Noda T, Wada H, Kobayashi S, Doki Y, Eguchi H. Miyahara S, et al. Among authors: wada h. Ann Surg Oncol. 2024 May;31(5):2971-2972. doi: 10.1245/s10434-024-15021-5. Epub 2024 Feb 16. Ann Surg Oncol. 2024. PMID: 38363472 No abstract available.
Prognostic Significance of Biologic Factors in Patients with a Modest Radiologic Response to Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancers: Impact of the Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers.
Miyahara S, Takahashi H, Akita H, Sasaki K, Mukai Y, Iwagami Y, Hasegawa S, Yamada D, Tomimaru Y, Noda T, Wada H, Kobayashi S, Doki Y, Eguchi H. Miyahara S, et al. Among authors: wada h. Ann Surg Oncol. 2024 May;31(5):2932-2942. doi: 10.1245/s10434-024-14945-2. Epub 2024 Feb 17. Ann Surg Oncol. 2024. PMID: 38368291
Assessing Intra-abdominal status for clinically relevant postoperative pancreatic fistula based on postoperative fluid collection and drain amylase levels after distal pancreatectomy.
Mukai Y, Asukai K, Akita H, Kubo M, Hasegawa S, Wada H, Miyata H, Ohue M, Sakon M, Takahashi H. Mukai Y, et al. Among authors: wada h. Ann Gastroenterol Surg. 2023 Sep 18;8(2):321-331. doi: 10.1002/ags3.12741. eCollection 2024 Mar. Ann Gastroenterol Surg. 2023. PMID: 38455495 Free PMC article.
Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma.
Nakabori T, Higashi S, Abe Y, Mukai K, Ikawa T, Konishi K, Maeda N, Nakanishi K, Hasegawa S, Wada H, Ohkawa K. Nakabori T, et al. Among authors: wada h. Curr Oncol. 2024 Mar 15;31(3):1543-1555. doi: 10.3390/curroncol31030117. Curr Oncol. 2024. PMID: 38534950 Free PMC article.
4,032 results